학술논문
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Document Type
Article
Author
Source
In The Lancet Infectious Diseases February 2021 21(2):181-192
Subject
Language
ISSN
1473-3099